Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies... Show more
The 10-day moving average for AKBLF crossed bullishly above the 50-day moving average on October 07, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 22 cases where AKBLF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for AKBLF just turned positive on September 18, 2025. Looking at past instances where AKBLF's MACD turned positive, the stock continued to rise in of 22 cases over the following month. The odds of a continued upward trend are .
AKBLF moved above its 50-day moving average on October 07, 2025 date and that indicates a change from a downward trend to an upward trend.
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AKBLF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.893) is normal, around the industry mean (24.455). P/E Ratio (46.482) is within average values for comparable stocks, (54.854). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.181). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (7.943) is also within normal values, averaging (352.090).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry Biotechnology
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SUPL | 37.76 | 0.35 | +0.94% |
ProShares Supply Chain Logistics ETF | |||
LFAR | 148.67 | N/A | N/A |
Stone Ridge 2057 Longevity Income ETF | |||
USCI | 76.91 | N/A | -0.01% |
United States Commodity Index | |||
THY | 22.53 | -0.06 | -0.27% |
Toews Agility Dynamic Tactical Inc ETF | |||
USXF | 56.81 | -0.30 | -0.53% |
iShares® ESG Advanced MSCI USA ETF |
A.I.dvisor tells us that AKBLF and MNPR have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKBLF and MNPR's prices will move in lockstep.
Ticker / NAME | Correlation To AKBLF | 1D Price Change % | ||
---|---|---|---|---|
AKBLF | 100% | +11.74% | ||
MNPR - AKBLF | 29% Poorly correlated | -5.21% | ||
MSCLF - AKBLF | 27% Poorly correlated | +7.55% | ||
IOVA - AKBLF | 26% Poorly correlated | +5.42% | ||
SMMT - AKBLF | 25% Poorly correlated | +4.09% | ||
VBIZF - AKBLF | 24% Poorly correlated | -19.96% | ||
More |